EYA1 expression and subcellular localization in neuroblastoma and its association with prognostic markers
Journal Title: Journal of Cancer Research & Therapy - Year 2016, Vol 4, Issue 2
Abstract
Neuroblastoma, the most frequently occurring extracranial solid tumor of childhood, arises from neural crest-derived cells that are arrested at an early stage of differentiation in the developing sympathetic nervous system. There is an urgent need to identify clinically relevant biomarkers for better prognosis and treatment of this aggressive malignancy. Eyes Absent 1 (EYA1) is an essential transcriptional coactivator for neuronal developmental programs during organogenesis. Whether or not EYA1 is implicated in neuroblastoma and subcellular localization of EYA1 is relevant to clinical behaviour of neuroblastoma is not known. We studied EYA1 expression and subcellular localization by immunohistochemistry in tissue microarrays containing tumor specimens from 98 patients, 66 of which were characterized by known clinical prognostic markers of neuroblastoma. Immunostaining results were evaluated and statistically correlated with the degree of histologic differentiation and with neuroblastoma risk stratification group characteristics, including stage of disease, patient age, tumor histology and mitosis–karyorrhexis index (MKI), respectively. We found that EYA1 levels were significantly higher in neuroblastomas than in ganglioneuromas and ganglioneuroblastomas. EYA1 was more highly expressed in stage 1,2,3 or 4S tumors as compared to stage 4 tumors (P<0.01). Tumors with high levels of nuclear EYA1 were more frequently associated with high nuclear MYCN levels. These results suggest that modulation of expression and intracellular localization of EYA1 in neural crest cells may provide a novel direction for therapeutic strategies.
Authors and Affiliations
Hansen JN, Lotta LT Jr, Eberhardt A, Schor NF, Li X
Keywords
Related Articles
- EP ID EP541643
- DOI 10.14312/2052-4994.2016-3
- Views 67
- Downloads 0
Primary small cell neuroendocrine carcinoma of the breast: The histogenetic diatribe
The histogenesis is still unclear because the presence of neuroendocrine cells in normal breast has not been proved conclusively.
Malignant solitary fibrous tumor of the sacrum: A case report
The solitary fibrous tumor (SFT) is a rare ubiquitous mesenchymal neoplasm of fibroblastic type, which shows a prominent hemangiopericytoma-like branching vascular pattern. Approximately 40% of solitary fibrous tumors ar...
Lichenoid mucocutaneous syndrome a variant of para neoplastic pemphigus (PNP) following the treatment of follicular non-Hodgkin’s lymphoma with fludarabine
Background: Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous disease associated with cancer. Since the original description of the condition, various publications have suggested the presence of a heterogeneo...
Diagnostic problems and immune contexture in a case of cecal medullary carcinoma
Medullary carcinoma (MC) of the colon has recently been described as a separate variant of colorectal carcinoma, associated with microsatellite instability. Despite its morphological similarities to poorly differentiated...
CIGB-128, as compassionate intracranial treatment in patients with non-operable or progressive high grade gliomas
Background: High grade glioma (HGG) is the most aggressive and lethal primary brain tumor. The treatment of patients with HGG still remains palliative with improvement in the quality of life and encompasses surgery, radi...